These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 19134543)

  • 1. Atorvastatin pleiotropic effects mediated via suppression of TNF-alpha in congestive heart failure patients with initial normal TNF-alpha levels.
    Kotyla PJ
    J Heart Lung Transplant; 2009 Jan; 28(1):114-5. PubMed ID: 19134543
    [No Abstract]   [Full Text] [Related]  

  • 2. Atorvastatin treatment improves endothelial function through endothelial progenitor cells mobilization in ischemic heart failure patients.
    Oikonomou E; Siasos G; Zaromitidou M; Hatzis G; Mourouzis K; Chrysohoou C; Zisimos K; Mazaris S; Tourikis P; Athanasiou D; Stefanadis C; Papavassiliou AG; Tousoulis D
    Atherosclerosis; 2015 Feb; 238(2):159-64. PubMed ID: 25525743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and autonomic function in chronic heart failure.
    van der Harst P; Voors AA; van Gilst WH; van Veldhuisen DJ
    Cardiovasc Drugs Ther; 2005 May; 19(3):167-8. PubMed ID: 16142591
    [No Abstract]   [Full Text] [Related]  

  • 4. Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation.
    Shechter M
    Circulation; 2003 Jun; 107(22):e210; author reply e210. PubMed ID: 12796420
    [No Abstract]   [Full Text] [Related]  

  • 5. Rhabdomyolysis in a patient receiving atorvastatin and fluconazole.
    Kahri J; Valkonen M; Bäcklund T; Vuoristo M; Kivistö KT
    Eur J Clin Pharmacol; 2005 Feb; 60(12):905-7. PubMed ID: 15625612
    [No Abstract]   [Full Text] [Related]  

  • 6. Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity.
    Castro PF; Miranda R; Verdejo HE; Greig D; Gabrielli LA; Alcaino H; Chiong M; Bustos C; Garcia L; Mellado R; Vukasovic JL; Godoy I; Lavandero S
    J Heart Lung Transplant; 2008 Apr; 27(4):435-41. PubMed ID: 18374881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of tachyphylaxis on statin treatment.
    Miserez AR; Keller U; Mirsaidi R
    Am J Cardiol; 2001 Oct; 88(8):936-7. PubMed ID: 11676971
    [No Abstract]   [Full Text] [Related]  

  • 8. Alopecia associated with atorvastatin.
    Segal AS
    Am J Med; 2002 Aug; 113(2):171. PubMed ID: 12133763
    [No Abstract]   [Full Text] [Related]  

  • 9. Statin therapy for patients with chronic heart failure.
    Gong K; Song G; Zhang Z
    Am J Cardiol; 2006 Sep; 98(5):707. PubMed ID: 16923467
    [No Abstract]   [Full Text] [Related]  

  • 10. Does "anti-lipid" also mean "anti-arrhythmic"?
    Esberg D; Kowey P
    J Card Fail; 2005 Dec; 11(9):691-2. PubMed ID: 16360964
    [No Abstract]   [Full Text] [Related]  

  • 11. Atorvastatin and statins in the treatment of heart failure.
    Horwich TB; MacLellan WR
    Expert Opin Pharmacother; 2007 Dec; 8(17):3061-8. PubMed ID: 18001265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of the atorvastatin-clopidogrel drug-drug interaction.
    Lau WC; Carville DG; Bates ER
    Circulation; 2004 Aug; 110(6):e66-7; author reply e66-7. PubMed ID: 15302813
    [No Abstract]   [Full Text] [Related]  

  • 13. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 14. Causal structures for evaluating statin class effects.
    Seeger JD
    Ann Pharmacother; 2002 Dec; 36(12):1961-5. PubMed ID: 12494951
    [No Abstract]   [Full Text] [Related]  

  • 15. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
    Malhotra HS; Goa KL
    Drugs; 2001; 61(12):1835-81. PubMed ID: 11693468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential statin-clopidogrel interaction requires more study.
    Williams D; Ford I; Hawksworth G
    Circulation; 2004 Aug; 110(6):e68; author reply e68. PubMed ID: 15302814
    [No Abstract]   [Full Text] [Related]  

  • 17. Statin-associated myotoxicity in an incarcerated Indigenous youth - the perfect storm.
    Haysom L; Samaras K; Stapylton C; Wines J
    Med J Aust; 2015 Apr; 202(7):381-2. PubMed ID: 25877122
    [No Abstract]   [Full Text] [Related]  

  • 18. Short-term effects of atorvastatin in normal dogs and dogs with congestive heart failure due to myxomatous mitral valve disease.
    Cunningham SM; Rush JE; Freeman LM
    J Vet Intern Med; 2013; 27(4):985-9. PubMed ID: 23758137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatic injury with atorvastatin: an unusual occurrence.
    Vishwakarma P; Nehra R; Kumar A
    Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible atorvastatin-associated external ophthalmoplegia, anti-acetylcholine receptor antibodies, and ataxia.
    Negevesky GJ; Kolsky MP; Laureno R; Yau TH
    Arch Ophthalmol; 2000 Mar; 118(3):427-8. PubMed ID: 10721974
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.